Survival of women with type I and II epithelial ovarian cancer detected by ultrasound screening

John R. Van Nagell, Brian T. Burgess, Rachel W. Miller, Lauren Baldwin, Christopher P. DeSimone, Frederick R. Ueland, Bin Huang, Quan Chen, Richard J. Kryscio, Edward J. Pavlik

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

OBJECTIVE: To estimate the effect of ultrasound screening on stage at detection and long-term disease-specific survival of at-risk women with epithelial ovarian cancer. METHODS: Eligibility included all asymptomatic women 50 years of age or older and women 25 years of age or older with a documented family history of ovarian cancer. From 1987 to 2017, 46,101 women received annual ultrasound screening in a prospective cohort trial. Women with a persisting abnormal screen underwent tumor morphology indexing, serum biomarker analysis, and surgery. RESULTS: Seventy-one invasive epithelial ovarian cancers and 17 epithelial ovarian tumors of low malignant potential were detected. No women with a low malignant potential tumor experienced recurrent disease. Stage distribution for screen-detected invasive epithelial ovarian cancers was stage I-30 (42%), stage II-15 (21%), stage III-26 (37%), and stage IV-0 (0%). Follow-up varied from 9.2 months to 27 years (mean 7.9 years). Disease-specific survival at 5, 10, and 20 years for women with invasive epithelial ovarian cancer detected by screening was 8664%, 6867%, and 6567%, respectively, vs 4562%, 3162%, and 1963%, respectively, for unscreened women with clinically detected ovarian cancer from the same geographic area who were treated at the same institution by the same treatment protocols (P,.001). Twenty-seven percent of screen-detected malignancies were type I and 73% were type II. The disease-specific survival of women with type I and type II screen-detected tumors was significantly higher than that of women with clinically detected type I and type II tumors and was related directly to earlier stage at detection. CONCLUSION: Annual ultrasound screening of at-risk asymptomatic women was associated with lower stage at detection and increased 5-, 10-, and 20-year disease-specific survival of women with both type I and type II epithelial ovarian cancer.

Original languageEnglish
Pages (from-to)1091-1100
Number of pages10
JournalObstetrics and Gynecology
Volume132
Issue number5
DOIs
StatePublished - 2018

Bibliographical note

Funding Information:
Supported by research grants from the Kentucky Department of Health and Human Services and the Telford Foundation.

Publisher Copyright:
© 2018 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Survival of women with type I and II epithelial ovarian cancer detected by ultrasound screening'. Together they form a unique fingerprint.

Cite this